Type 2 Diabetes mellitus Samples

The category Type 2 Diabetes mellitus Samples includes human serum specimens which were measured for the following laboratory parameters: Hepatitis B Virus surface Antigen, Hepatitis C Virus ribonucleic acid, HIV-1-RNA, Neuron-specific enolase and Prostate specific antigen. You can use our filter functions to perform complex searches according to laboratory parameters, diseases, medication such as Actaphane, Actrapid, Actrapiol, Adenuric or Apidra, ICD-10 code, donor age and gender as well as donor ethnicity and BMI. For normal control groups please switch to the category Healthy Donors. If you do not find the research samples you are looking for, please contact our Central BioHub team.

Available filters
-
-
351 Products

Human Sodium heparin plasma - Anti-Thyroid peroxidase (aTPO / MAK),... - E03.9

Donor:
Gender: Female Age: 75 Ethnic group: European/Caucasian
Diagnosed disease:
E11.90
Medication:
Euthyrox
Parameter:
Anti-Thyroid peroxidase (aTPO / MAK) TSH Receptor Antibodies (TRAb) Thyrotropin (TSH) Thyroxine (FT4) Triiodothyronine (FT3)
Donor:
Gender:
Female
Age:
75 Years
Ethnic group:
European/Caucasian
BMI:
26 kg/m²
Weight:
74.5 kg
Height:
168 cm
Sample:
Matrix:
Sodium heparin plasma
Condition:
perfect
Freeze-Thaw-Cycle:
0
Diseases:
  • Hypothyroidism, unspecified [E03.9]
  • Thyrotoxicosis with diffuse goitre [E05.0]
  • E11.90
  • hypertension
  • hypoparathyroidism - partial (not specified)
Medication:
  • Euthyrox (Dosages: 112µg)
  • Lantus (active agent: insulin glargin)
  • Metoprolol
  • Novorapid (active agent: insulin aspart)
  • simvastatine
Parameter Result Ref. / Cut-Off Measuring Information
Anti-Thyroid peroxidase (aTPO / MAK)
Qual:
Quant: 16.30 not specified
Source: previous donation
not specified not specified
Method: not specified
System: not specified not specified
TSH Receptor Antibodies (TRAb)
Qual:
Quant: 24.27 not specified
Source: previous donation
not specified not specified
Method: not specified
System: not specified not specified
Thyrotropin (TSH)
Qual:
Quant: 0.73 not specified
Source: previous donation
not specified not specified
Method: not specified
System: not specified not specified
Thyroxine (FT4)
Qual:
Quant: 18.40 not specified
Source: previous donation
not specified not specified
Method: not specified
System: not specified not specified
Triiodothyronine (FT3)
Qual:
Quant: 2.30 not specified
Source: previous donation
not specified not specified
Method: not specified
System: not specified not specified
Disclaimer
  • All products are for research or manufacturing purposes only and are not for direct therapeutic or diagnostic use in human or animals.
  • Biospecimens should be treated as potentially infectious. Each specimen is intended for use only in by qualified professionals who will safely handle and dispose of the products they receive.
  • Import permit for biological substances must be present for purchase.
  • This sample is not for molecular genetic studies.
CBH147121
1 mL ($43.13)
Will be delivered in 16 to 20 Business Days ($225.00)

Human Li-heparin plasma - Anti-Thyroid peroxidase (aTPO / MAK),... - E03.9

Donor:
Gender: Female Age: 75 Ethnic group: European/Caucasian
Diagnosed disease:
E11.90
Medication:
Euthyrox
Parameter:
Anti-Thyroid peroxidase (aTPO / MAK) TSH Receptor Antibodies (TRAb) Thyrotropin (TSH) Thyroxine (FT4) Triiodothyronine (FT3)
Donor:
Gender:
Female
Age:
75 Years
Ethnic group:
European/Caucasian
BMI:
26 kg/m²
Weight:
74.5 kg
Height:
168 cm
Sample:
Matrix:
Li-heparin plasma
Condition:
perfect
Freeze-Thaw-Cycle:
0
Diseases:
  • Hypothyroidism, unspecified [E03.9]
  • Thyrotoxicosis with diffuse goitre [E05.0]
  • E11.90
  • hypertension
  • hypoparathyroidism - partial (not specified)
Medication:
  • Euthyrox (Dosages: 112µg)
  • Lantus (active agent: insulin glargin)
  • Metoprolol
  • Novorapid (active agent: insulin aspart)
  • simvastatine
Parameter Result Ref. / Cut-Off Measuring Information
Anti-Thyroid peroxidase (aTPO / MAK)
Qual:
Quant: 16.30 not specified
Source: previous donation
not specified not specified
Method: not specified
System: not specified not specified
TSH Receptor Antibodies (TRAb)
Qual:
Quant: 24.27 not specified
Source: previous donation
not specified not specified
Method: not specified
System: not specified not specified
Thyrotropin (TSH)
Qual:
Quant: 0.73 not specified
Source: previous donation
not specified not specified
Method: not specified
System: not specified not specified
Thyroxine (FT4)
Qual:
Quant: 18.40 not specified
Source: previous donation
not specified not specified
Method: not specified
System: not specified not specified
Triiodothyronine (FT3)
Qual:
Quant: 2.30 not specified
Source: previous donation
not specified not specified
Method: not specified
System: not specified not specified
Disclaimer
  • All products are for research or manufacturing purposes only and are not for direct therapeutic or diagnostic use in human or animals.
  • Biospecimens should be treated as potentially infectious. Each specimen is intended for use only in by qualified professionals who will safely handle and dispose of the products they receive.
  • Import permit for biological substances must be present for purchase.
  • This sample is not for molecular genetic studies.
CBH147118
1 mL ($43.13)
Will be delivered in 16 to 20 Business Days ($225.00)

Human K3EDTA plasma - Anti-Thyroid peroxidase (aTPO / MAK),... - E03.9

Donor:
Gender: Female Age: 75 Ethnic group: European/Caucasian
Diagnosed disease:
E11.90
Medication:
Euthyrox
Parameter:
Anti-Thyroid peroxidase (aTPO / MAK) TSH Receptor Antibodies (TRAb) Thyrotropin (TSH) Thyroxine (FT4) Triiodothyronine (FT3)
Donor:
Gender:
Female
Age:
75 Years
Ethnic group:
European/Caucasian
BMI:
26 kg/m²
Weight:
74.5 kg
Height:
168 cm
Sample:
Matrix:
K3EDTA plasma
Condition:
perfect
Freeze-Thaw-Cycle:
0
Diseases:
  • Hypothyroidism, unspecified [E03.9]
  • Thyrotoxicosis with diffuse goitre [E05.0]
  • E11.90
  • hypertension
  • hypoparathyroidism - partial (not specified)
Medication:
  • Euthyrox (Dosages: 112µg)
  • Lantus (active agent: insulin glargin)
  • Metoprolol
  • Novorapid (active agent: insulin aspart)
  • simvastatine
Parameter Result Ref. / Cut-Off Measuring Information
Anti-Thyroid peroxidase (aTPO / MAK)
Qual:
Quant: 16.30 not specified
Source: previous donation
not specified not specified
Method: not specified
System: not specified not specified
TSH Receptor Antibodies (TRAb)
Qual:
Quant: 24.27 not specified
Source: previous donation
not specified not specified
Method: not specified
System: not specified not specified
Thyrotropin (TSH)
Qual:
Quant: 0.73 not specified
Source: previous donation
not specified not specified
Method: not specified
System: not specified not specified
Thyroxine (FT4)
Qual:
Quant: 18.40 not specified
Source: previous donation
not specified not specified
Method: not specified
System: not specified not specified
Triiodothyronine (FT3)
Qual:
Quant: 2.30 not specified
Source: previous donation
not specified not specified
Method: not specified
System: not specified not specified
Disclaimer
  • All products are for research or manufacturing purposes only and are not for direct therapeutic or diagnostic use in human or animals.
  • Biospecimens should be treated as potentially infectious. Each specimen is intended for use only in by qualified professionals who will safely handle and dispose of the products they receive.
  • Import permit for biological substances must be present for purchase.
  • This sample is not for molecular genetic studies.
CBH147115
1 mL ($43.13)
Will be delivered in 16 to 20 Business Days ($225.00)

Human Serum - Anti-Thyroid peroxidase (aTPO / MAK),... - E03.9

Donor:
Gender: Female Age: 75 Ethnic group: European/Caucasian
Diagnosed disease:
E11.90
Medication:
Euthyrox
Parameter:
Anti-Thyroid peroxidase (aTPO / MAK) TSH Receptor Antibodies (TRAb) Thyrotropin (TSH) Thyroxine (FT4) Triiodothyronine (FT3)
Donor:
Gender:
Female
Age:
75 Years
Ethnic group:
European/Caucasian
BMI:
26 kg/m²
Weight:
74.5 kg
Height:
168 cm
Sample:
Matrix:
Serum
Condition:
perfect
Freeze-Thaw-Cycle:
0
Diseases:
  • Hypothyroidism, unspecified [E03.9]
  • Thyrotoxicosis with diffuse goitre [E05.0]
  • E11.90
  • hypertension
  • hypoparathyroidism - partial (not specified)
Medication:
  • Euthyrox (Dosages: 112µg)
  • Lantus (active agent: insulin glargin)
  • Metoprolol
  • Novorapid (active agent: insulin aspart)
  • simvastatine
Parameter Result Ref. / Cut-Off Measuring Information
Anti-Thyroid peroxidase (aTPO / MAK)
Qual:
Quant: 16.30 not specified
Source: previous donation
not specified not specified
Method: not specified
System: not specified not specified
TSH Receptor Antibodies (TRAb)
Qual:
Quant: 24.27 not specified
Source: previous donation
not specified not specified
Method: not specified
System: not specified not specified
Thyrotropin (TSH)
Qual:
Quant: 0.73 not specified
Source: previous donation
not specified not specified
Method: not specified
System: not specified not specified
Thyroxine (FT4)
Qual:
Quant: 18.40 not specified
Source: previous donation
not specified not specified
Method: not specified
System: not specified not specified
Triiodothyronine (FT3)
Qual:
Quant: 2.30 not specified
Source: previous donation
not specified not specified
Method: not specified
System: not specified not specified
Disclaimer
  • All products are for research or manufacturing purposes only and are not for direct therapeutic or diagnostic use in human or animals.
  • Biospecimens should be treated as potentially infectious. Each specimen is intended for use only in by qualified professionals who will safely handle and dispose of the products they receive.
  • Import permit for biological substances must be present for purchase.
  • This sample is not for molecular genetic studies.
CBH147114
1 mL ($43.13)
Will be delivered in 16 to 20 Business Days ($225.00)

Human Serum - E11.90

Donor:
Gender: Female Age: 63 Ethnic group: European/Caucasian
Diagnosed disease:
E11.90 - type 2 (not specified)
Medication:
insulin
Parameter:
Anti-Hepatitis C Virus (HCV) Anti-Human Immunodeficiency Virus-1/2 (HIV-1/2) Hepatitis B Virus surface Antigen (HBsAg)
Donor:
Gender:
Female
Age:
63 Years
Ethnic group:
European/Caucasian
BMI:
56 kg/m²
Weight:
152 kg
Height:
165 cm
Sample:
Matrix:
Serum
Condition:
perfect
Stored at:
< -18 degrees Celsius
Freeze-Thaw-Cycle:
0
Diseases:
  • diabetes mellitus [E11.90] - type 2 (not specified)
  • hypertension
  • sleep apnoea
Medication:
  • insulin
  • metformin
Therapy:
  • cardiac valve replacement
  • thyroid surgery
Parameter Result Ref. / Cut-Off Measuring Information
Anti-Hepatitis C Virus (HCV)
Qual: negative
Quant:
Source: this donation
negative
Method: CMIA (Chemiluminescence Micro Particle Immuno Assay)
System: Architect i 2000 sr Abbott Diagnostics
Anti-Human Immunodeficiency Virus-1/2 (HIV-1/2)
Qual: negative
Quant:
Source: this donation
negative
Method: CMIA (Chemiluminescence Micro Particle Immuno Assay)
System: Architect i 2000 sr Abbott Diagnostics
Hepatitis B Virus surface Antigen (HBsAg)
Qual: negative
Quant:
Source: this donation
negative
Method: CMIA (Chemiluminescence Micro Particle Immuno Assay)
System: Architect i 2000 sr Abbott Diagnostics
Disclaimer
  • All products are for research or manufacturing purposes only and are not for direct therapeutic or diagnostic use in human or animals.
  • Biospecimens should be treated as potentially infectious. Each specimen is intended for use only in by qualified professionals who will safely handle and dispose of the products they receive.
  • Import permit for biological substances must be present for purchase.
  • This sample is not for molecular genetic studies.
CBH146089
1 mL ($43.13)
Will be delivered in 16 to 20 Business Days ($225.00)

Human Serum - Glycosylated hemoglobin (HbA1, HbA1c) - E11.90

Donor:
Gender: Male Age: 68 Ethnic group: European/Caucasian
Diagnosed disease:
E11.90 - type 2 (not specified)
Medication:
DPP-4 inhibitor
Parameter:
Anti-Hepatitis C Virus (HCV) Anti-Human Immunodeficiency Virus-1/2 (HIV-1/2) Glycosylated hemoglobin (HbA1, HbA1c) Hepatitis B Virus surface Antigen (HBsAg)
Donor:
Gender:
Male
Age:
68 Years
Ethnic group:
European/Caucasian
BMI:
30 kg/m²
Weight:
98 kg
Height:
180 cm
Sample:
Matrix:
Serum
Condition:
perfect
Stored at:
< -18 degrees Celsius
Freeze-Thaw-Cycle:
0
Diseases:
  • diabetes mellitus [E11.90] - type 2 (not specified)
  • thyroid disease
Medication:
  • DPP-4 inhibitor
  • blood thinner (because of stroke)
  • metformin
  • no incretin mimetics
  • no insulin
Parameter Result Ref. / Cut-Off Measuring Information
Anti-Hepatitis C Virus (HCV)
Qual: negative
Quant:
Source: this donation
negative
Method: CMIA (Chemiluminescence Micro Particle Immuno Assay)
System: Architect i 2000 sr Abbott
Anti-Human Immunodeficiency Virus-1/2 (HIV-1/2)
Qual: negative
Quant:
Source: this donation
negative
Method: CMIA (Chemiluminescence Micro Particle Immuno Assay)
System: Architect i 2000 sr Abbott
Glycosylated hemoglobin (HbA1, HbA1c)
Qual:
Quant: 3.10 %
Source: previous donation
not specified not specified
Method: not specified
System: not specified not specified
Hepatitis B Virus surface Antigen (HBsAg)
Qual: negative
Quant:
Source: this donation
negative
Method: CMIA (Chemiluminescence Micro Particle Immuno Assay)
System: Architect i 2000 sr Abbott
Disclaimer
  • All products are for research or manufacturing purposes only and are not for direct therapeutic or diagnostic use in human or animals.
  • Biospecimens should be treated as potentially infectious. Each specimen is intended for use only in by qualified professionals who will safely handle and dispose of the products they receive.
  • Import permit for biological substances must be present for purchase.
  • This sample is not for molecular genetic studies.
CBH170468
1 mL ($43.13)
Will be delivered in 16 to 20 Business Days ($225.00)

Human Serum - E11.90

Donor:
Gender: Female Age: 83 Ethnic group: European/Caucasian
Diagnosed disease:
E11.90 - type 2 (not specified)
Medication:
ASS
Parameter:
Anti-Hepatitis C Virus (HCV) Anti-Human Immunodeficiency Virus-1/2 (HIV-1/2) Hepatitis B Virus surface Antigen (HBsAg)
Donor:
Gender:
Female
Age:
83 Years
Ethnic group:
European/Caucasian
BMI:
30 kg/m²
Weight:
75 kg
Height:
158 cm
Sample:
Matrix:
Serum
Condition:
perfect
Stored at:
< -18 degrees Celsius
Freeze-Thaw-Cycle:
0
Diseases:
  • diabetes mellitus [E11.90] - type 2 (not specified)
Medication:
  • ASS
  • Metoprolol
  • Ramipril
  • amlodipine
  • no incretin mimetics
  • no insulin
  • none
Parameter Result Ref. / Cut-Off Measuring Information
Anti-Hepatitis C Virus (HCV)
Qual: negative
Quant:
Source: this donation
negative
Method: CMIA (Chemiluminescence Micro Particle Immuno Assay)
System: Architect i 2000 sr Abbott
Anti-Human Immunodeficiency Virus-1/2 (HIV-1/2)
Qual: negative
Quant:
Source: this donation
negative
Method: CMIA (Chemiluminescence Micro Particle Immuno Assay)
System: Architect i 2000 sr Abbott
Hepatitis B Virus surface Antigen (HBsAg)
Qual: negative
Quant:
Source: this donation
negative
Method: CMIA (Chemiluminescence Micro Particle Immuno Assay)
System: Architect i 2000 sr Abbott
Disclaimer
  • All products are for research or manufacturing purposes only and are not for direct therapeutic or diagnostic use in human or animals.
  • Biospecimens should be treated as potentially infectious. Each specimen is intended for use only in by qualified professionals who will safely handle and dispose of the products they receive.
  • Import permit for biological substances must be present for purchase.
  • This sample is not for molecular genetic studies.
CBH169795
1 mL ($43.13)
Will be delivered in 16 to 20 Business Days ($225.00)

Human Serum - Glycosylated hemoglobin (HbA1, HbA1c) - E11.90

Donor:
Gender: Female Age: 54 Ethnic group: European/Caucasian
Diagnosed disease:
E11.90 - type 2 (reliable diagnosis)
Medication:
DuoTrav
Parameter:
Anti-Hepatitis C Virus (HCV) Anti-Human Immunodeficiency Virus-1/2 (HIV-1/2) Glycosylated hemoglobin (HbA1, HbA1c) Hepatitis B Virus surface Antigen (HBsAg)
Donor:
Gender:
Female
Age:
54 Years
Ethnic group:
European/Caucasian
BMI:
29 kg/m²
Weight:
89 kg
Height:
174 cm
Sample:
Matrix:
Serum
Condition:
perfect
Stored at:
< -18 degrees Celsius
Freeze-Thaw-Cycle:
0
Diseases:
  • diabetes mellitus [E11.90] - type 2 (reliable diagnosis)
  • glaucoma
  • hypothyroidism
Medication:
  • DuoTrav (Dosages: 1drop/day)
  • Janumet
  • L-thyroxine (Dosages: 125/day)
  • no incretin mimetics
  • no insulin
Parameter Result Ref. / Cut-Off Measuring Information
Anti-Hepatitis C Virus (HCV)
Qual: negative
Quant:
Source: this donation
negative
Method: CMIA (Chemiluminescence Micro Particle Immuno Assay)
System: Architect i 2000 sr Abbott Diagnostics
Anti-Human Immunodeficiency Virus-1/2 (HIV-1/2)
Qual: negative
Quant:
Source: this donation
negative
Method: CMIA (Chemiluminescence Micro Particle Immuno Assay)
System: Architect i 2000 sr Abbott Diagnostics
Glycosylated hemoglobin (HbA1, HbA1c)
Qual:
Quant: 6.50 %
Source: previous donation
not specified not specified
Method: not specified
System: not specified not specified
Hepatitis B Virus surface Antigen (HBsAg)
Qual: negative
Quant:
Source: this donation
negative
Method: CMIA (Chemiluminescence Micro Particle Immuno Assay)
System: Architect i 2000 sr Abbott Diagnostics
Disclaimer
  • All products are for research or manufacturing purposes only and are not for direct therapeutic or diagnostic use in human or animals.
  • Biospecimens should be treated as potentially infectious. Each specimen is intended for use only in by qualified professionals who will safely handle and dispose of the products they receive.
  • Import permit for biological substances must be present for purchase.
  • This sample is not for molecular genetic studies.
CBH142240
1 mL ($43.13)
Will be delivered in 16 to 20 Business Days ($225.00)

Human Serum - Glycosylated hemoglobin (HbA1, HbA1c) - E11.2

Donor:
Gender: Female Age: 67 Ethnic group: European/Caucasian
Diagnosed disease:
E11.2 - Type 2 diabetes mellitus with renal complications - type 2 (not specified)
Medication:
L-thyroxine
Parameter:
Anti-Hepatitis C Virus (HCV) Anti-Human Immunodeficiency Virus-1/2 (HIV-1/2) Glycosylated hemoglobin (HbA1, HbA1c) Hepatitis B Virus surface Antigen (HBsAg)
Donor:
Gender:
Female
Age:
67 Years
Ethnic group:
European/Caucasian
BMI:
29 kg/m²
Weight:
89 kg
Height:
174 cm
Sample:
Matrix:
Serum
Condition:
perfect
Stored at:
< -18 degrees Celsius
Freeze-Thaw-Cycle:
0
Diseases:
  • Hashimotos thyroiditis
  • diabetes mellitus [E11.2] - type 2 (not specified)
  • hypertension
  • hyperuricaemia
Medication:
  • L-thyroxine (Dosages: 37.5not specified)
  • Ramipril (Dosages: 5mg/day)
  • allopurinol (Dosages: 100mg/day)
  • metformin (Dosages: 1500/day)
  • no incretin mimetics
  • no insulin
Parameter Result Ref. / Cut-Off Measuring Information
Anti-Hepatitis C Virus (HCV)
Qual: negative
Quant:
Source: this donation
negative
Method: CMIA (Chemiluminescence Micro Particle Immuno Assay)
System: Architect i 2000 sr Abbott Diagnostics
Anti-Human Immunodeficiency Virus-1/2 (HIV-1/2)
Qual: negative
Quant:
Source: this donation
negative
Method: CMIA (Chemiluminescence Micro Particle Immuno Assay)
System: Architect i 2000 sr Abbott Diagnostics
Glycosylated hemoglobin (HbA1, HbA1c)
Qual:
Quant: 7.10 not specified
Source: previous donation
not specified not specified
Method: not specified
System: not specified not specified
Hepatitis B Virus surface Antigen (HBsAg)
Qual: negative
Quant:
Source: this donation
negative
Method: CMIA (Chemiluminescence Micro Particle Immuno Assay)
System: Architect i 2000 sr Abbott Diagnostics
Disclaimer
  • All products are for research or manufacturing purposes only and are not for direct therapeutic or diagnostic use in human or animals.
  • Biospecimens should be treated as potentially infectious. Each specimen is intended for use only in by qualified professionals who will safely handle and dispose of the products they receive.
  • Import permit for biological substances must be present for purchase.
  • This sample is not for molecular genetic studies.
CBH143042
1 mL ($43.13)
Will be delivered in 16 to 20 Business Days ($225.00)

Human Serum - Blood glucose (postprandial), Glycosy... - E11.9

Donor:
Gender: Female Age: 65 Ethnic group: European/Caucasian
Diagnosed disease:
E11.9 - Type 2 diabetes mellitus without complications - type 2 (not specified)
Medication:
metformin
Parameter:
Anti-Hepatitis C Virus (HCV) Anti-Human Immunodeficiency Virus-1/2 (HIV-1/2) Blood glucose (postprandial) Glycosylated hemoglobin (HbA1, HbA1c) Hepatitis B Virus surface Antigen (HBsAg)
Donor:
Gender:
Female
Age:
65 Years
Ethnic group:
European/Caucasian
BMI:
33 kg/m²
Weight:
85 kg
Height:
161 cm
Sample:
Matrix:
Serum
Condition:
perfect
Stored at:
< -18 degrees Celsius
Freeze-Thaw-Cycle:
0
Diseases:
  • asthma
  • diabetes mellitus [E11.9] - type 2 (not specified)
Medication:
  • metformin
  • no insulin
Parameter Result Ref. / Cut-Off Measuring Information
Anti-Hepatitis C Virus (HCV)
Qual: negative
Quant:
Source: this donation
negative
Method: CMIA (Chemiluminescence Micro Particle Immuno Assay)
System: Architect i 2000 sr Abbott Diagnostics
Anti-Human Immunodeficiency Virus-1/2 (HIV-1/2)
Qual: negative
Quant:
Source: this donation
negative
Method: CMIA (Chemiluminescence Micro Particle Immuno Assay)
System: Architect i 2000 sr Abbott Diagnostics
Blood glucose (postprandial)
Qual:
Quant: 132.00 mg/dl
Source: this donation
not specified not specified
Method: not specified
System: not specified not specified
Glycosylated hemoglobin (HbA1, HbA1c)
Qual:
Quant: 5.70 %
Source: previous donation
not specified not specified
Method: not specified
System: not specified not specified
Hepatitis B Virus surface Antigen (HBsAg)
Qual: negative
Quant:
Source: this donation
negative
Method: CMIA (Chemiluminescence Micro Particle Immuno Assay)
System: Architect i 2000 sr Abbott Diagnostics
Disclaimer
  • All products are for research or manufacturing purposes only and are not for direct therapeutic or diagnostic use in human or animals.
  • Biospecimens should be treated as potentially infectious. Each specimen is intended for use only in by qualified professionals who will safely handle and dispose of the products they receive.
  • Import permit for biological substances must be present for purchase.
  • This sample is not for molecular genetic studies.
CBH165494
1 mL ($43.13)
Will be delivered in 16 to 20 Business Days ($225.00)

Human Serum - E11.90

Donor:
Gender: Female Age: 79 Ethnic group: European/Caucasian
Diagnosed disease:
E11.90
Medication:
Bisoprolol
Parameter:
Anti-Hepatitis C Virus (HCV) Anti-Human Immunodeficiency Virus-1/2 (HIV-1/2) Hepatitis B Virus surface Antigen (HBsAg)
Donor:
Gender:
Female
Age:
79 Years
Ethnic group:
European/Caucasian
BMI:
32 kg/m²
Weight:
75 kg
Height:
153 cm
Sample:
Matrix:
Serum
Condition:
perfect
Stored at:
< -18 degrees Celsius
Freeze-Thaw-Cycle:
0
Diseases:
  • diabetes mellitus [E11.90]
  • gastritis
  • hyperlipoproteinaemia
  • hypertension
Medication:
  • Bisoprolol
  • Ramipril
  • Xarelto
  • no incretin mimetics
  • no insulin
Parameter Result Ref. / Cut-Off Measuring Information
Anti-Hepatitis C Virus (HCV)
Qual: negative
Quant:
Source: this donation
negative
Method: CMIA (Chemiluminescence Micro Particle Immuno Assay)
System: Architect i 2000 sr Abbott Diagnostics
Anti-Human Immunodeficiency Virus-1/2 (HIV-1/2)
Qual: negative
Quant:
Source: this donation
negative
Method: CMIA (Chemiluminescence Micro Particle Immuno Assay)
System: Architect i 2000 sr Abbott Diagnostics
Hepatitis B Virus surface Antigen (HBsAg)
Qual: negative
Quant:
Source: this donation
negative
Method: CMIA (Chemiluminescence Micro Particle Immuno Assay)
System: Architect i 2000 sr Abbott Diagnostics
Disclaimer
  • All products are for research or manufacturing purposes only and are not for direct therapeutic or diagnostic use in human or animals.
  • Biospecimens should be treated as potentially infectious. Each specimen is intended for use only in by qualified professionals who will safely handle and dispose of the products they receive.
  • Import permit for biological substances must be present for purchase.
  • This sample is not for molecular genetic studies.
CBH165539
1 mL ($43.13)
Will be delivered in 16 to 20 Business Days ($225.00)

Human Serum - Glycosylated hemoglobin (HbA1, HbA1c) - E11.90

Donor:
Gender: Male Age: 64 Ethnic group: European/Caucasian
Diagnosed disease:
E11.90 - type 2 (not specified)
Medication:
DPP-4 inhibitor
Parameter:
Anti-Hepatitis C Virus (HCV) Anti-Human Immunodeficiency Virus-1/2 (HIV-1/2) Glycosylated hemoglobin (HbA1, HbA1c) Hepatitis B Virus surface Antigen (HBsAg)
Donor:
Gender:
Male
Age:
64 Years
Ethnic group:
European/Caucasian
BMI:
36 kg/m²
Weight:
128 kg
Height:
188 cm
Sample:
Matrix:
Serum
Condition:
perfect
Stored at:
< -18 degrees Celsius
Freeze-Thaw-Cycle:
0
Diseases:
  • coronary heart disease
  • diabetes mellitus [E11.90] - type 2 (not specified)
  • hypertension
Medication:
  • DPP-4 inhibitor
  • metformin
  • no incretin mimetics
  • no insulin
Parameter Result Ref. / Cut-Off Measuring Information
Anti-Hepatitis C Virus (HCV)
Qual: negative
Quant:
Source: this donation
negative
Method: CMIA (Chemiluminescence Micro Particle Immuno Assay)
System: Architect i 2000 sr Abbott
Anti-Human Immunodeficiency Virus-1/2 (HIV-1/2)
Qual: negative
Quant:
Source: this donation
negative
Method: CMIA (Chemiluminescence Micro Particle Immuno Assay)
System: Architect i 2000 sr Abbott
Glycosylated hemoglobin (HbA1, HbA1c)
Qual:
Quant: 6.20 %
Source: previous donation
not specified not specified
Method: not specified
System: not specified not specified
Hepatitis B Virus surface Antigen (HBsAg)
Qual: negative
Quant:
Source: this donation
negative
Method: CMIA (Chemiluminescence Micro Particle Immuno Assay)
System: Architect i 2000 sr Abbott Diagnostics
Hepatitis B Virus surface Antigen (HBsAg)
Qual: negative
Quant:
Source: this donation
negative
Method: CMIA (Chemiluminescence Micro Particle Immuno Assay)
System: Architect i 2000 sr Abbott
Disclaimer
  • All products are for research or manufacturing purposes only and are not for direct therapeutic or diagnostic use in human or animals.
  • Biospecimens should be treated as potentially infectious. Each specimen is intended for use only in by qualified professionals who will safely handle and dispose of the products they receive.
  • Import permit for biological substances must be present for purchase.
  • This sample is not for molecular genetic studies.
CBH165470
1 mL ($43.13)
Will be delivered in 16 to 20 Business Days ($225.00)

Human Serum - Blood sugar (fasting), Glycosylated h... - E11.9

Donor:
Gender: Female Age: 74 Ethnic group: European/Caucasian
Diagnosed disease:
E11.9 - Type 2 diabetes mellitus without complications - type 2 (not specified)
Medication:
incretin mimetics
Parameter:
Anti-Hepatitis C Virus (HCV) Anti-Human Immunodeficiency Virus-1/2 (HIV-1/2) Blood sugar (fasting) Glycosylated hemoglobin (HbA1, HbA1c) Hepatitis B Virus surface Antigen (HBsAg)
Donor:
Gender:
Female
Age:
74 Years
Ethnic group:
European/Caucasian
BMI:
29 kg/m²
Weight:
68.8 kg
Height:
155 cm
Sample:
Matrix:
Serum
Condition:
perfect
Stored at:
< -18 degrees Celsius
Freeze-Thaw-Cycle:
0
Diseases:
  • diabetes mellitus [E11.9] - type 2 (not specified)
  • hypothyroidism
Medication:
  • incretin mimetics
  • metformin
  • no insulin
Parameter Result Ref. / Cut-Off Measuring Information
Anti-Hepatitis C Virus (HCV)
Qual: negative
Quant:
Source: this donation
negative
Method: CMIA (Chemiluminescence Micro Particle Immuno Assay)
System: Architect i 2000 sr Abbott Diagnostics
Anti-Human Immunodeficiency Virus-1/2 (HIV-1/2)
Qual: negative
Quant:
Source: this donation
negative
Method: CMIA (Chemiluminescence Micro Particle Immuno Assay)
System: Architect i 2000 sr Abbott Diagnostics
Blood sugar (fasting)
Qual:
Quant: 78.00 mg/dl
Source: this donation
not specified not specified
Method: not specified
System: not specified not specified
Glycosylated hemoglobin (HbA1, HbA1c)
Qual:
Quant: 6.30 %
Source: previous donation
not specified not specified
Method: not specified
System: not specified not specified
Hepatitis B Virus surface Antigen (HBsAg)
Qual: negative
Quant:
Source: this donation
negative
Method: CMIA (Chemiluminescence Micro Particle Immuno Assay)
System: Architect i 2000 sr Abbott Diagnostics
Disclaimer
  • All products are for research or manufacturing purposes only and are not for direct therapeutic or diagnostic use in human or animals.
  • Biospecimens should be treated as potentially infectious. Each specimen is intended for use only in by qualified professionals who will safely handle and dispose of the products they receive.
  • Import permit for biological substances must be present for purchase.
  • This sample is not for molecular genetic studies.
CBH165492
1 mL ($43.13)
Will be delivered in 16 to 20 Business Days ($225.00)

Human Serum - Blood sugar (fasting), Glycosylated h... - E11.9

Donor:
Gender: Female Age: 75 Ethnic group: European/Caucasian
Diagnosed disease:
E11.9 - Type 2 diabetes mellitus without complications - type 2 (not specified)
Medication:
L-thyroxine
Parameter:
Blood sugar (fasting) Glycosylated hemoglobin (HbA1, HbA1c)
Donor:
Gender:
Female
Age:
75 Years
Ethnic group:
European/Caucasian
BMI:
41 kg/m²
Weight:
112 kg
Height:
165 cm
Sample:
Matrix:
Serum
Condition:
perfect
Stored at:
< -18 degrees Celsius
Freeze-Thaw-Cycle:
0
Diseases:
  • diabetes mellitus [E11.9] - type 2 (not specified)
  • thyroid disease
Medication:
  • L-thyroxine
  • Toujeo (specific information from donor: Toujeo 300 U/ml)
  • atorvastatin
  • insulin
  • no incretin mimetics
Parameter Result Ref. / Cut-Off Measuring Information
Blood sugar (fasting)
Qual:
Quant: 135.00 mg/dl
Source: this donation
not specified not specified
Method: not specified
System: not specified not specified
Glycosylated hemoglobin (HbA1, HbA1c)
Qual:
Quant: 7.60 %
Source: previous donation
not specified not specified
Method: not specified
System: not specified not specified
Disclaimer
  • All products are for research or manufacturing purposes only and are not for direct therapeutic or diagnostic use in human or animals.
  • Biospecimens should be treated as potentially infectious. Each specimen is intended for use only in by qualified professionals who will safely handle and dispose of the products they receive.
  • Import permit for biological substances must be present for purchase.
  • This sample is not for molecular genetic studies.
CBH165497
1 mL ($43.13)
Will be delivered in 16 to 20 Business Days ($225.00)

Human Serum - Glycosylated hemoglobin (HbA1, HbA1c) - E11.9

Donor:
Gender: Female Age: 50 Ethnic group: European/Caucasian
Diagnosed disease:
E11.9 - Type 2 diabetes mellitus without complications - type 2 (not specified)
Medication:
Metex
Parameter:
Anti-Hepatitis C Virus (HCV) Anti-Human Immunodeficiency Virus-1/2 (HIV-1/2) Glycosylated hemoglobin (HbA1, HbA1c) Hepatitis B Virus surface Antigen (HBsAg)
Donor:
Gender:
Female
Age:
50 Years
Ethnic group:
European/Caucasian
BMI:
31 kg/m²
Weight:
90 kg
Height:
170 cm
Sample:
Matrix:
Serum
Condition:
perfect
Stored at:
< -18 degrees Celsius
Freeze-Thaw-Cycle:
0
Diseases:
  • diabetes mellitus [E11.9] - type 2 (not specified)
  • rheumatism - 01 (not specified)
  • thyroid disease - 01 (not specified)
Medication:
  • Metex
  • Novorapid
  • Protaphan
  • insulin
  • metformin
Parameter Result Ref. / Cut-Off Measuring Information
Anti-Hepatitis C Virus (HCV)
Qual: negative
Quant:
Source: this donation
negative
Method: CMIA (Chemiluminescence Micro Particle Immuno Assay)
System: Architect i 2000 sr Abbott
Anti-Human Immunodeficiency Virus-1/2 (HIV-1/2)
Qual: negative
Quant:
Source: this donation
negative
Method: CMIA (Chemiluminescence Micro Particle Immuno Assay)
System: Architect i 2000 sr Abbott
Glycosylated hemoglobin (HbA1, HbA1c)
Qual:
Quant: 6.30 %
Source: previous donation
not specified not specified
Method: not specified
System: not specified not specified
Hepatitis B Virus surface Antigen (HBsAg)
Qual: negative
Quant:
Source: this donation
negative
Method: CMIA (Chemiluminescence Micro Particle Immuno Assay)
System: Architect i 2000 sr Abbott
Disclaimer
  • All products are for research or manufacturing purposes only and are not for direct therapeutic or diagnostic use in human or animals.
  • Biospecimens should be treated as potentially infectious. Each specimen is intended for use only in by qualified professionals who will safely handle and dispose of the products they receive.
  • Import permit for biological substances must be present for purchase.
  • This sample is not for molecular genetic studies.
CBH165636
1 mL ($43.13)
Will be delivered in 16 to 20 Business Days ($225.00)

Human Serum - Blood glucose (postprandial), Glycosy... - E78.2

Donor:
Gender: Female Age: 41 Ethnic group: Not specified
Diagnosed disease:
E11.9 - Type 2 diabetes mellitus without complications - type 2 (not specified)
Medication:
Prednisolon
Parameter:
Anti-Hepatitis C Virus (HCV) Anti-Human Immunodeficiency Virus-1/2 (HIV-1/2) Blood glucose (postprandial) Glycosylated hemoglobin (HbA1, HbA1c) Hepatitis B Virus surface Antigen (HBsAg)
Donor:
Gender:
Female
Age:
41 Years
Ethnic group:
Not specified
BMI:
32 kg/m²
Weight:
84 kg
Height:
162 cm
Sample:
Matrix:
Serum
Condition:
perfect
Stored at:
< -18 degrees Celsius
Freeze-Thaw-Cycle:
0
Diseases:
  • Mixed hyperlipidaemia [E78.2]
  • diabetes mellitus [E11.9] - type 2 (not specified)
Medication:
  • Prednisolon (specific information from donor: Prednisolon 5 mg)
  • insulin
  • metformin
  • no incretin mimetics
Parameter Result Ref. / Cut-Off Measuring Information
Anti-Hepatitis C Virus (HCV)
Qual: negative
Quant:
Source: this donation
negative
Method: CMIA (Chemiluminescence Micro Particle Immuno Assay)
System: Architect i 2000 sr Abbott
Anti-Human Immunodeficiency Virus-1/2 (HIV-1/2)
Qual: negative
Quant:
Source: this donation
negative
Method: CMIA (Chemiluminescence Micro Particle Immuno Assay)
System: Architect i 2000 sr Abbott
Blood glucose (postprandial)
Qual:
Quant: 173 mg/dl
Source: this donation
Method: not specified
Glycosylated hemoglobin (HbA1, HbA1c)
Qual:
Quant: 7.10 %
Source: previous donation
not specified not specified
Method: not specified
System: not specified not specified
Glycosylated hemoglobin (HbA1, HbA1c)
Qual:
Quant: 7.30 %
Source: previous donation
not specified not specified
Method: not specified
System: not specified not specified
Hepatitis B Virus surface Antigen (HBsAg)
Qual: negative
Quant:
Source: this donation
negative
Method: CMIA (Chemiluminescence Micro Particle Immuno Assay)
System: Architect i 2000 sr Abbott
Disclaimer
  • All products are for research or manufacturing purposes only and are not for direct therapeutic or diagnostic use in human or animals.
  • Biospecimens should be treated as potentially infectious. Each specimen is intended for use only in by qualified professionals who will safely handle and dispose of the products they receive.
  • Import permit for biological substances must be present for purchase.
  • This sample is not for molecular genetic studies.
CBH165459
1 mL ($43.13)
Will be delivered in 16 to 20 Business Days ($225.00)

Human Serum - Glycosylated hemoglobin (HbA1, HbA1c) - E11.90

Donor:
Gender: Female Age: 72 Ethnic group: European/Caucasian
Diagnosed disease:
E11.90
Medication:
Candesartan
Parameter:
Anti-Hepatitis C Virus (HCV) Anti-Human Immunodeficiency Virus-1/2 (HIV-1/2) Glycosylated hemoglobin (HbA1, HbA1c) Hepatitis B Virus surface Antigen (HBsAg)
Donor:
Gender:
Female
Age:
72 Years
Ethnic group:
European/Caucasian
BMI:
30 kg/m²
Weight:
84 kg
Height:
168 cm
Sample:
Matrix:
Serum
Condition:
perfect
Stored at:
< -18 degrees Celsius
Freeze-Thaw-Cycle:
0
Diseases:
  • diabetes mellitus [E11.90]
  • hypertension
  • polyarthritis
Medication:
  • Candesartan
  • amlodipine
  • metfomin
  • no incretin mimetics
  • no insulin
Parameter Result Ref. / Cut-Off Measuring Information
Anti-Hepatitis C Virus (HCV)
Qual: negative
Quant:
Source: this donation
negative
Method: CMIA (Chemiluminescence Micro Particle Immuno Assay)
System: Architect i 2000 sr Abbott Diagnostics
Anti-Human Immunodeficiency Virus-1/2 (HIV-1/2)
Qual: negative
Quant:
Source: this donation
negative
Method: CMIA (Chemiluminescence Micro Particle Immuno Assay)
System: Architect i 2000 sr Abbott Diagnostics
Glycosylated hemoglobin (HbA1, HbA1c)
Qual:
Quant: 6.7 %
Source: previous donation
not specified not specified
Method: not specified
System: not specified not specified
Hepatitis B Virus surface Antigen (HBsAg)
Qual: negative
Quant:
Source: this donation
negative
Method: CMIA (Chemiluminescence Micro Particle Immuno Assay)
System: Architect i 2000 sr Abbott Diagnostics
Disclaimer
  • All products are for research or manufacturing purposes only and are not for direct therapeutic or diagnostic use in human or animals.
  • Biospecimens should be treated as potentially infectious. Each specimen is intended for use only in by qualified professionals who will safely handle and dispose of the products they receive.
  • Import permit for biological substances must be present for purchase.
  • This sample is not for molecular genetic studies.
CBH165508
1 mL ($43.13)
Will be delivered in 16 to 20 Business Days ($225.00)

Human Serum - E11.90

Donor:
Gender: Female Age: 72 Ethnic group: European/Caucasian
Diagnosed disease:
E11.90
Medication:
Nebivolol
Parameter:
Anti-Hepatitis C Virus (HCV) Anti-Human Immunodeficiency Virus-1/2 (HIV-1/2) Hepatitis B Virus surface Antigen (HBsAg)
Donor:
Gender:
Female
Age:
72 Years
Ethnic group:
European/Caucasian
BMI:
32 kg/m²
Weight:
80 kg
Height:
158 cm
Sample:
Matrix:
Serum
Condition:
perfect
Stored at:
< -18 degrees Celsius
Freeze-Thaw-Cycle:
0
Diseases:
  • diabetes mellitus [E11.90]
  • hyperlipoproteinaemia
  • hypertension
Medication:
  • Nebivolol
  • amlodipine
  • metfomin
  • no incretin mimetics
  • no insulin
  • simvastatine
Parameter Result Ref. / Cut-Off Measuring Information
Anti-Hepatitis C Virus (HCV)
Qual: negative
Quant:
Source: this donation
negative
Method: CMIA (Chemiluminescence Micro Particle Immuno Assay)
System: Architect i 2000 sr Abbott Diagnostics
Anti-Human Immunodeficiency Virus-1/2 (HIV-1/2)
Qual: negative
Quant:
Source: this donation
negative
Method: CMIA (Chemiluminescence Micro Particle Immuno Assay)
System: Architect i 2000 sr Abbott Diagnostics
Hepatitis B Virus surface Antigen (HBsAg)
Qual: negative
Quant:
Source: this donation
negative
Method: CMIA (Chemiluminescence Micro Particle Immuno Assay)
System: Architect i 2000 sr Abbott Diagnostics
Disclaimer
  • All products are for research or manufacturing purposes only and are not for direct therapeutic or diagnostic use in human or animals.
  • Biospecimens should be treated as potentially infectious. Each specimen is intended for use only in by qualified professionals who will safely handle and dispose of the products they receive.
  • Import permit for biological substances must be present for purchase.
  • This sample is not for molecular genetic studies.
CBH165537
1 mL ($43.13)
Will be delivered in 16 to 20 Business Days ($225.00)

Human Serum - E11.90

Donor:
Gender: Female Age: 75 Ethnic group: European/Caucasian
Diagnosed disease:
E11.90
Medication:
L-thyroxine
Parameter:
Hepatitis B Virus surface Antigen (HBsAg) Hepatitis C Virus ribonucleic acid (HCV-RNA) Human Immunodeficiency Virus type 1 ribonucleic acid (HIV-1-RNA)
Donor:
Gender:
Female
Age:
75 Years
Ethnic group:
European/Caucasian
BMI:
18 kg/m²
Weight:
52 kg
Height:
160 cm
Sample:
Matrix:
Serum
Condition:
perfect
Stored at:
< -18 degrees Celsius
Freeze-Thaw-Cycle:
0
Diseases:
  • E11.90
  • atrial fibrillation
Medication:
  • L-thyroxine (specific information from donor: L-thyroxine 100)
  • metformin
  • no insulin
Therapy:
  • surgery
Parameter Result Ref. / Cut-Off Measuring Information
Hepatitis B Virus surface Antigen (HBsAg)
Qual: negative
Quant:
Source: this donation
negative
Method: CMIA (Chemiluminescence Micro Particle Immuno Assay)
System: Architect i 2000 sr Abbott Diagnostics
Hepatitis C Virus ribonucleic acid (HCV-RNA)
Qual: negative
Quant:
Source: this donation
negative
Method: qPCR (Real-Time Quantitative PCR)
System: Cobas Ampliprep/Cobas TaqMan Roche
Human Immunodeficiency Virus type 1 ribonucleic acid (HIV-1-RNA)
Qual: negative
Quant:
Source: this donation
negative
Method: PCR (Polymerase Chain Reaction)
System: Cobas Ampliprep/Cobas TaqMan Roche
Disclaimer
  • All products are for research or manufacturing purposes only and are not for direct therapeutic or diagnostic use in human or animals.
  • Biospecimens should be treated as potentially infectious. Each specimen is intended for use only in by qualified professionals who will safely handle and dispose of the products they receive.
  • Import permit for biological substances must be present for purchase.
  • This sample is not for molecular genetic studies.
CBH165346
1 mL ($86.25)
Will be delivered in 16 to 20 Business Days ($225.00)

Human Serum - Blood glucose (postprandial), Glycosy... - E11.9

Donor:
Gender: Female Age: 73 Ethnic group: European/Caucasian
Diagnosed disease:
E11.9 - Type 2 diabetes mellitus without complications - type 2 (not specified)
Medication:
Lantus
Parameter:
Anti-Hepatitis C Virus (HCV) Anti-Human Immunodeficiency Virus-1/2 (HIV-1/2) Blood glucose (postprandial) Glycosylated hemoglobin (HbA1, HbA1c) Hepatitis B Virus surface Antigen (HBsAg)
Donor:
Gender:
Female
Age:
73 Years
Ethnic group:
European/Caucasian
BMI:
38 kg/m²
Weight:
71.5 kg
Height:
138 cm
Sample:
Matrix:
Serum
Condition:
perfect
Stored at:
< -18 degrees Celsius
Freeze-Thaw-Cycle:
0
Diseases:
  • diabetes mellitus [E11.9] - type 2 (not specified)
Medication:
  • Lantus
  • Liprolog
  • insulin
  • no incretin mimetics
Parameter Result Ref. / Cut-Off Measuring Information
Anti-Hepatitis C Virus (HCV)
Qual: negative
Quant:
Source: this donation
negative
Method: CMIA (Chemiluminescence Micro Particle Immuno Assay)
System: Architect i 2000 sr Abbott
Anti-Human Immunodeficiency Virus-1/2 (HIV-1/2)
Qual: negative
Quant:
Source: this donation
negative
Method: CMIA (Chemiluminescence Micro Particle Immuno Assay)
System: Architect i 2000 sr Abbott
Blood glucose (postprandial)
Qual:
Quant: 149.00 mg/dl
Source: previous donation
not specified not specified
Method: not specified
System: not specified not specified
Glycosylated hemoglobin (HbA1, HbA1c)
Qual:
Quant: 7.20 %
Source: previous donation
not specified not specified
Method: not specified
System: not specified not specified
Hepatitis B Virus surface Antigen (HBsAg)
Qual: negative
Quant:
Source: this donation
negative
Method: CMIA (Chemiluminescence Micro Particle Immuno Assay)
System: Architect i 2000 sr Abbott
Disclaimer
  • All products are for research or manufacturing purposes only and are not for direct therapeutic or diagnostic use in human or animals.
  • Biospecimens should be treated as potentially infectious. Each specimen is intended for use only in by qualified professionals who will safely handle and dispose of the products they receive.
  • Import permit for biological substances must be present for purchase.
  • This sample is not for molecular genetic studies.
CBH170850
1 mL ($43.13)
Will be delivered in 16 to 20 Business Days ($225.00)

Human Serum - Glycosylated hemoglobin (HbA1, HbA1c) - E11.90

Donor:
Gender: Male Age: 69 Ethnic group: European/Caucasian
Diagnosed disease:
E11.90 - type 2 (reliable diagnosis)
Medication:
metformin
Parameter:
Anti-Hepatitis C Virus (HCV) Anti-Human Immunodeficiency Virus-1/2 (HIV-1/2) Glycosylated hemoglobin (HbA1, HbA1c) Hepatitis B Virus surface Antigen (HBsAg)
Donor:
Gender:
Male
Age:
69 Years
Ethnic group:
European/Caucasian
BMI:
28 kg/m²
Weight:
83 kg
Height:
172 cm
Sample:
Matrix:
Serum
Condition:
perfect
Stored at:
< -18 degrees Celsius
Freeze-Thaw-Cycle:
0
Diseases:
  • diabetes mellitus [E11.90] - type 2 (reliable diagnosis)
Medication:
  • metformin
  • no incretin mimetics
  • no insulin
Therapy:
  • implant
Parameter Result Ref. / Cut-Off Measuring Information
Anti-Hepatitis C Virus (HCV)
Qual: negative
Quant:
Source: this donation
negative
Method: CMIA (Chemiluminescence Micro Particle Immuno Assay)
System: Architect i 2000 sr Abbott
Anti-Human Immunodeficiency Virus-1/2 (HIV-1/2)
Qual: negative
Quant:
Source: this donation
negative
Method: CMIA (Chemiluminescence Micro Particle Immuno Assay)
System: Architect i 2000 sr Abbott
Glycosylated hemoglobin (HbA1, HbA1c)
Qual:
Quant: 6.20 not specified
Source: previous donation
not specified not specified
Method: not specified
System: not specified not specified
Hepatitis B Virus surface Antigen (HBsAg)
Qual: negative
Quant:
Source: this donation
negative
Method: CMIA (Chemiluminescence Micro Particle Immuno Assay)
System: Architect i 2000 sr Abbott
Disclaimer
  • All products are for research or manufacturing purposes only and are not for direct therapeutic or diagnostic use in human or animals.
  • Biospecimens should be treated as potentially infectious. Each specimen is intended for use only in by qualified professionals who will safely handle and dispose of the products they receive.
  • Import permit for biological substances must be present for purchase.
  • This sample is not for molecular genetic studies.
CBH166126
1 mL ($43.13)
Will be delivered in 16 to 20 Business Days ($225.00)

Human Serum - E11.21

Donor:
Gender: Female Age: 76 Ethnic group: Not specified
Diagnosed disease:
E11.21
Medication:
Januvia
Parameter:
Anti-Hepatitis C Virus (HCV) Anti-Human Immunodeficiency Virus-1/2 (HIV-1/2) Hepatitis B Virus surface Antigen (HBsAg)
Donor:
Gender:
Female
Age:
76 Years
Ethnic group:
Not specified
BMI:
27 kg/m²
Weight:
68 kg
Height:
158 cm
Sample:
Matrix:
Serum
Condition:
perfect
Stored at:
< -18 degrees Celsius
Freeze-Thaw-Cycle:
0
Diseases:
  • diabetes mellitus [E11.21]
Medication:
  • Januvia (specific information from donor: Januvia 50 mg)
  • Losartan (specific information from donor: Losartan 100 mg)
  • Prednisolon (specific information from donor: Prednisolon 1 mg)
  • insulin
  • no incretin mimetics
Parameter Result Ref. / Cut-Off Measuring Information
Anti-Hepatitis C Virus (HCV)
Qual: negative
Quant:
Source: this donation
negative
Method: CMIA (Chemiluminescence Micro Particle Immuno Assay)
System: Architect i 2000 sr Abbott
Anti-Human Immunodeficiency Virus-1/2 (HIV-1/2)
Qual: negative
Quant:
Source: this donation
negative
Method: CMIA (Chemiluminescence Micro Particle Immuno Assay)
System: Architect i 2000 sr Abbott
Hepatitis B Virus surface Antigen (HBsAg)
Qual: negative
Quant:
Source: this donation
negative
Method: CMIA (Chemiluminescence Micro Particle Immuno Assay)
System: Architect i 2000 sr Abbott
Disclaimer
  • All products are for research or manufacturing purposes only and are not for direct therapeutic or diagnostic use in human or animals.
  • Biospecimens should be treated as potentially infectious. Each specimen is intended for use only in by qualified professionals who will safely handle and dispose of the products they receive.
  • Import permit for biological substances must be present for purchase.
  • This sample is not for molecular genetic studies.
CBH165523
1 mL ($43.13)
Will be delivered in 16 to 20 Business Days ($225.00)

Human Serum - Blood glucose (postprandial), Glycosy... - E11.9

Donor:
Gender: Female Age: 60 Ethnic group: Not specified
Diagnosed disease:
E11.9 - Type 2 diabetes mellitus without complications - type 2 (not specified)
Medication:
metformin
Parameter:
Anti-Hepatitis C Virus (HCV) Anti-Human Immunodeficiency Virus-1/2 (HIV-1/2) Blood glucose (postprandial) Glycosylated hemoglobin (HbA1, HbA1c) Hepatitis B Virus surface Antigen (HBsAg)
Donor:
Gender:
Female
Age:
60 Years
Ethnic group:
Not specified
BMI:
30 kg/m²
Weight:
79 kg
Height:
162 cm
Sample:
Matrix:
Serum
Condition:
perfect
Stored at:
< -18 degrees Celsius
Freeze-Thaw-Cycle:
0
Diseases:
  • diabetes mellitus [E11.9] - type 2 (not specified)
Medication:
  • metformin
  • no incretin mimetics
  • no insulin
Parameter Result Ref. / Cut-Off Measuring Information
Anti-Hepatitis C Virus (HCV)
Qual: negative
Quant:
Source: this donation
negative
Method: CMIA (Chemiluminescence Micro Particle Immuno Assay)
System: Architect i 2000 sr Abbott
Anti-Human Immunodeficiency Virus-1/2 (HIV-1/2)
Qual: negative
Quant:
Source: this donation
negative
Method: CMIA (Chemiluminescence Micro Particle Immuno Assay)
System: Architect i 2000 sr Abbott
Blood glucose (postprandial)
Qual:
Quant: 107.00 mg/dl
Source: this donation
not specified not specified
Method: not specified
System: not specified not specified
Glycosylated hemoglobin (HbA1, HbA1c)
Qual:
Quant: 6.30 %
Source: previous donation
not specified not specified
Method: not specified
System: not specified not specified
Hepatitis B Virus surface Antigen (HBsAg)
Qual: negative
Quant:
Source: this donation
negative
Method: CMIA (Chemiluminescence Micro Particle Immuno Assay)
System: Architect i 2000 sr Abbott
Disclaimer
  • All products are for research or manufacturing purposes only and are not for direct therapeutic or diagnostic use in human or animals.
  • Biospecimens should be treated as potentially infectious. Each specimen is intended for use only in by qualified professionals who will safely handle and dispose of the products they receive.
  • Import permit for biological substances must be present for purchase.
  • This sample is not for molecular genetic studies.
CBH165575
1 mL ($43.13)
Will be delivered in 16 to 20 Business Days ($225.00)

Human Serum - E11.9

Donor:
Gender: Male Age: 80 Ethnic group: European/Caucasian
Diagnosed disease:
E11.9 - Type 2 diabetes mellitus without complications - type 2 (not specified)
Medication:
Actrapid
Parameter:
Anti-Hepatitis C Virus (HCV) Anti-Human Immunodeficiency Virus-1/2 (HIV-1/2) Hepatitis B Virus surface Antigen (HBsAg)
Donor:
Gender:
Male
Age:
80 Years
Ethnic group:
European/Caucasian
BMI:
28 kg/m²
Weight:
98 kg
Height:
187 cm
Sample:
Matrix:
Serum
Condition:
perfect
Stored at:
< -18 degrees Celsius
Freeze-Thaw-Cycle:
0
Diseases:
  • diabetes mellitus [E11.9] - type 2 (not specified)
Medication:
  • Actrapid
  • Toujeo
  • insulin
  • metformin
  • no incretin mimetics
Parameter Result Ref. / Cut-Off Measuring Information
Anti-Hepatitis C Virus (HCV)
Qual: negative
Quant:
Source: this donation
negative
Method: CMIA (Chemiluminescence Micro Particle Immuno Assay)
System: Architect i 2000 sr Abbott
Anti-Human Immunodeficiency Virus-1/2 (HIV-1/2)
Qual: negative
Quant:
Source: this donation
negative
Method: CMIA (Chemiluminescence Micro Particle Immuno Assay)
System: Architect i 2000 sr Abbott
Hepatitis B Virus surface Antigen (HBsAg)
Qual: negative
Quant:
Source: this donation
negative
Method: CMIA (Chemiluminescence Micro Particle Immuno Assay)
System: Architect i 2000 sr Abbott
Disclaimer
  • All products are for research or manufacturing purposes only and are not for direct therapeutic or diagnostic use in human or animals.
  • Biospecimens should be treated as potentially infectious. Each specimen is intended for use only in by qualified professionals who will safely handle and dispose of the products they receive.
  • Import permit for biological substances must be present for purchase.
  • This sample is not for molecular genetic studies.
CBH165634
1 mL ($43.13)
Will be delivered in 16 to 20 Business Days ($225.00)

Human Serum - Glycosylated hemoglobin (HbA1, HbA1c) - E11.9

Donor:
Gender: Male Age: 49 Ethnic group: Asian
Diagnosed disease:
E11.9 - Type 2 diabetes mellitus without complications - type 2 (not specified)
Medication:
L-thyroxine
Parameter:
Anti-Hepatitis C Virus (HCV) Anti-Human Immunodeficiency Virus-1/2 (HIV-1/2) Glycosylated hemoglobin (HbA1, HbA1c) Hepatitis B Virus surface Antigen (HBsAg)
Donor:
Gender:
Male
Age:
49 Years
Ethnic group:
Asian
BMI:
26 kg/m²
Weight:
99 kg
Height:
196 cm
Sample:
Matrix:
Serum
Condition:
perfect
Stored at:
< -18 degrees Celsius
Freeze-Thaw-Cycle:
0
Diseases:
  • diabetes mellitus [E11.9] - type 2 (not specified)
Medication:
  • L-thyroxine
  • Victoza
  • insulin
  • metformin
  • no incretin mimetics
Parameter Result Ref. / Cut-Off Measuring Information
Anti-Hepatitis C Virus (HCV)
Qual: negative
Quant:
Source: this donation
negative
Method: CMIA (Chemiluminescence Micro Particle Immuno Assay)
System: Architect i 2000 sr Abbott
Anti-Human Immunodeficiency Virus-1/2 (HIV-1/2)
Qual: negative
Quant:
Source: this donation
negative
Method: CMIA (Chemiluminescence Micro Particle Immuno Assay)
System: Architect i 2000 sr Abbott
Glycosylated hemoglobin (HbA1, HbA1c)
Qual:
Quant: 7.20 %
Source: previous donation
not specified not specified
Method: not specified
System: not specified not specified
Hepatitis B Virus surface Antigen (HBsAg)
Qual: negative
Quant:
Source: this donation
negative
Method: CMIA (Chemiluminescence Micro Particle Immuno Assay)
System: Architect i 2000 sr Abbott
Disclaimer
  • All products are for research or manufacturing purposes only and are not for direct therapeutic or diagnostic use in human or animals.
  • Biospecimens should be treated as potentially infectious. Each specimen is intended for use only in by qualified professionals who will safely handle and dispose of the products they receive.
  • Import permit for biological substances must be present for purchase.
  • This sample is not for molecular genetic studies.
CBH165485
1 mL ($43.13)
Will be delivered in 16 to 20 Business Days ($225.00)

Human Serum - Blood glucose (postprandial), Glycosy... - E11.9

Donor:
Gender: Male Age: 55 Ethnic group: European/Caucasian
Diagnosed disease:
E11.9 - Type 2 diabetes mellitus without complications - type 2 (not specified)
Medication:
insulin
Parameter:
Anti-Hepatitis C Virus (HCV) Anti-Human Immunodeficiency Virus-1/2 (HIV-1/2) Blood glucose (postprandial) Glycosylated hemoglobin (HbA1, HbA1c) Hepatitis B Virus surface Antigen (HBsAg)
Donor:
Gender:
Male
Age:
55 Years
Ethnic group:
European/Caucasian
BMI:
34 kg/m²
Weight:
105 kg
Height:
175 cm
Sample:
Matrix:
Serum
Condition:
perfect
Stored at:
< -18 degrees Celsius
Freeze-Thaw-Cycle:
0
Diseases:
  • diabetes mellitus [E11.9] - type 2 (not specified)
Medication:
  • insulin
  • metformin
  • no incretin mimetics
Parameter Result Ref. / Cut-Off Measuring Information
Anti-Hepatitis C Virus (HCV)
Qual: negative
Quant:
Source: this donation
negative
Method: CMIA (Chemiluminescence Micro Particle Immuno Assay)
System: Architect i 2000 sr Abbott
Anti-Human Immunodeficiency Virus-1/2 (HIV-1/2)
Qual: negative
Quant:
Source: this donation
negative
Method: CMIA (Chemiluminescence Micro Particle Immuno Assay)
System: Architect i 2000 sr Abbott
Blood glucose (postprandial)
Qual:
Quant: 250.00 mg/dl
Source: this donation
not specified not specified
Method: not specified
System: not specified not specified
Glycosylated hemoglobin (HbA1, HbA1c)
Qual:
Quant: > 14 %
Source: previous donation
not specified not specified
Method: not specified
System: not specified not specified
Hepatitis B Virus surface Antigen (HBsAg)
Qual: negative
Quant:
Source: this donation
negative
Method: CMIA (Chemiluminescence Micro Particle Immuno Assay)
System: Architect i 2000 sr Abbott
Disclaimer
  • All products are for research or manufacturing purposes only and are not for direct therapeutic or diagnostic use in human or animals.
  • Biospecimens should be treated as potentially infectious. Each specimen is intended for use only in by qualified professionals who will safely handle and dispose of the products they receive.
  • Import permit for biological substances must be present for purchase.
  • This sample is not for molecular genetic studies.
CBH165579
1 mL ($43.13)
Will be delivered in 16 to 20 Business Days ($225.00)

Human Serum - Blood glucose, Glycosylated hemoglobi... - E11.9

Donor:
Gender: Male Age: 73 Ethnic group: European/Caucasian
Diagnosed disease:
E11.9 - Type 2 diabetes mellitus without complications - type 2 (not specified)
Medication:
Lantus
Parameter:
Anti-Hepatitis C Virus (HCV) Anti-Human Immunodeficiency Virus-1/2 (HIV-1/2) Blood glucose Glycosylated hemoglobin (HbA1, HbA1c) Hepatitis B Virus surface Antigen (HBsAg)
Donor:
Gender:
Male
Age:
73 Years
Ethnic group:
European/Caucasian
BMI:
24 kg/m²
Weight:
71 kg
Height:
172 cm
Sample:
Matrix:
Serum
Condition:
perfect
Stored at:
< -18 degrees Celsius
Freeze-Thaw-Cycle:
0
Diseases:
  • diabetes mellitus [E11.9] - type 2 (not specified)
Medication:
  • Lantus
  • atorvastatin (specific information from donor: atorvastatin 20)
  • insulin
  • no incretin mimetics
Parameter Result Ref. / Cut-Off Measuring Information
Anti-Hepatitis C Virus (HCV)
Qual: negative
Quant:
Source: this donation
negative
Method: CMIA (Chemiluminescence Micro Particle Immuno Assay)
System: Architect i 2000 sr Abbott
Anti-Human Immunodeficiency Virus-1/2 (HIV-1/2)
Qual: negative
Quant:
Source: this donation
negative
Method: CMIA (Chemiluminescence Micro Particle Immuno Assay)
System: Architect i 2000 sr Abbott
Blood glucose
Qual:
Quant: < 6.5 %
Source: this donation
not specified not specified
Method: not specified
System: not specified not specified
Glycosylated hemoglobin (HbA1, HbA1c)
Qual:
Quant: 7.10 %
Source: previous donation
not specified not specified
Method: not specified
System: not specified not specified
Hepatitis B Virus surface Antigen (HBsAg)
Qual: negative
Quant:
Source: this donation
negative
Method: CMIA (Chemiluminescence Micro Particle Immuno Assay)
System: Architect i 2000 sr Abbott
Disclaimer
  • All products are for research or manufacturing purposes only and are not for direct therapeutic or diagnostic use in human or animals.
  • Biospecimens should be treated as potentially infectious. Each specimen is intended for use only in by qualified professionals who will safely handle and dispose of the products they receive.
  • Import permit for biological substances must be present for purchase.
  • This sample is not for molecular genetic studies.
CBH165577
1 mL ($43.13)
Will be delivered in 16 to 20 Business Days ($225.00)

Human Serum - Glycosylated hemoglobin (HbA1, HbA1c) - E11.

Donor:
Gender: Female Age: 70 Ethnic group: European/Caucasian
Diagnosed disease:
E11. - type 2 (not specified)
Medication:
Insulin
Parameter:
Anti-Hepatitis C Virus (HCV) Anti-Human Immunodeficiency Virus-1/2 (HIV-1/2) Glycosylated hemoglobin (HbA1, HbA1c) Hepatitis B Virus surface Antigen (HBsAg)
Donor:
Gender:
Female
Age:
70 Years
Ethnic group:
European/Caucasian
BMI:
32 kg/m²
Weight:
79 kg
Height:
158 cm
Sample:
Matrix:
Serum
Condition:
perfect
Stored at:
< -18 degrees Celsius
Freeze-Thaw-Cycle:
0
Diseases:
  • diabetes mellitus [E11.] - type 2 (not specified)
  • fibromyalgia
  • hepatic cirrhosis - early stadium (not specified)
  • hepatic fibrosis
  • hypertension
  • spinal stenosis
Medication:
  • Insulin
  • no incretin mimetics
Parameter Result Ref. / Cut-Off Measuring Information
Anti-Hepatitis C Virus (HCV)
Qual: negative
Quant:
Source: this donation
negative
Method: CMIA (Chemiluminescence Micro Particle Immuno Assay)
System: Architect i 2000 sr Abbott
Anti-Human Immunodeficiency Virus-1/2 (HIV-1/2)
Qual: negative
Quant:
Source: this donation
negative
Method: CMIA (Chemiluminescence Micro Particle Immuno Assay)
System: Architect i 2000 sr Abbott
Glycosylated hemoglobin (HbA1, HbA1c)
Qual:
Quant: 6.10 %
Source:
not specified not specified
Method: not specified
System: not specified not specified
Hepatitis B Virus surface Antigen (HBsAg)
Qual: negative
Quant:
Source: this donation
negative
Method: CMIA (Chemiluminescence Micro Particle Immuno Assay)
System: Architect i 2000 sr Abbott
Disclaimer
  • All products are for research or manufacturing purposes only and are not for direct therapeutic or diagnostic use in human or animals.
  • Biospecimens should be treated as potentially infectious. Each specimen is intended for use only in by qualified professionals who will safely handle and dispose of the products they receive.
  • Import permit for biological substances must be present for purchase.
  • This sample is not for molecular genetic studies.
CBH169862
1 mL ($43.13)
Will be delivered in 16 to 20 Business Days ($225.00)

Human Serum - Glycosylated hemoglobin (HbA1, HbA1c) - E11.90

Donor:
Gender: Male Age: 80 Ethnic group: European/Caucasian
Diagnosed disease:
E11.90 - type 2 (not specified)
Medication:
metformin
Parameter:
Anti-Hepatitis C Virus (HCV) Anti-Human Immunodeficiency Virus-1/2 (HIV-1/2) Glycosylated hemoglobin (HbA1, HbA1c) Hepatitis B Virus surface Antigen (HBsAg)
Donor:
Gender:
Male
Age:
80 Years
Ethnic group:
European/Caucasian
BMI:
24 kg/m²
Weight:
68 kg
Height:
167 cm
Sample:
Matrix:
Serum
Condition:
perfect
Stored at:
< -18 degrees Celsius
Freeze-Thaw-Cycle:
0
Diseases:
  • coronary heart disease
  • diabetes mellitus [E11.90] - type 2 (not specified)
  • hyperlipoproteinaemia
  • hypertension
  • osteochondrosis
  • polyarthrosis
Medication:
  • metformin
  • no incretin mimetics
  • no insulin
Parameter Result Ref. / Cut-Off Measuring Information
Anti-Hepatitis C Virus (HCV)
Qual: negative
Quant:
Source: this donation
negative
Method: CMIA (Chemiluminescence Micro Particle Immuno Assay)
System: Architect i 2000 sr Abbott
Anti-Human Immunodeficiency Virus-1/2 (HIV-1/2)
Qual: negative
Quant:
Source: this donation
negative
Method: CMIA (Chemiluminescence Micro Particle Immuno Assay)
System: Architect i 2000 sr Abbott
Glycosylated hemoglobin (HbA1, HbA1c)
Qual:
Quant: 6.90 %
Source:
not specified not specified
Method: not specified
System: not specified not specified
Hepatitis B Virus surface Antigen (HBsAg)
Qual: negative
Quant:
Source: this donation
negative
Method: CMIA (Chemiluminescence Micro Particle Immuno Assay)
System: Architect i 2000 sr Abbott
Disclaimer
  • All products are for research or manufacturing purposes only and are not for direct therapeutic or diagnostic use in human or animals.
  • Biospecimens should be treated as potentially infectious. Each specimen is intended for use only in by qualified professionals who will safely handle and dispose of the products they receive.
  • Import permit for biological substances must be present for purchase.
  • This sample is not for molecular genetic studies.
CBH169788
1 mL ($43.13)
Will be delivered in 16 to 20 Business Days ($225.00)

Human Serum - Glycosylated hemoglobin (HbA1, HbA1c) - E11.9

Donor:
Gender: Female Age: 57 Ethnic group: European/Caucasian
Diagnosed disease:
E11.9 - Type 2 diabetes mellitus without complications - type 2 (not specified)
Medication:
Irbesartan
Parameter:
Glycosylated hemoglobin (HbA1, HbA1c)
Donor:
Gender:
Female
Age:
57 Years
Ethnic group:
European/Caucasian
BMI:
32 kg/m²
Weight:
85 kg
Height:
163 cm
Sample:
Matrix:
Serum
Condition:
perfect
Stored at:
< -18 degrees Celsius
Freeze-Thaw-Cycle:
0
Diseases:
  • Hashimotos thyroiditis
  • Mnires disease
  • diabetes mellitus [E11.9] - type 2 (not specified)
  • hyperlipidaemia
  • hypertension
Medication:
  • Irbesartan
  • L-thyroxine (Dosages: 125not specified)
  • metformin
  • no incretin mimetics
  • no insulin
Parameter Result Ref. / Cut-Off Measuring Information
Glycosylated hemoglobin (HbA1, HbA1c)
Qual:
Quant: 6.50 %
Source: previous donation
not specified not specified
Method: not specified
System: not specified not specified
Disclaimer
  • All products are for research or manufacturing purposes only and are not for direct therapeutic or diagnostic use in human or animals.
  • Biospecimens should be treated as potentially infectious. Each specimen is intended for use only in by qualified professionals who will safely handle and dispose of the products they receive.
  • Import permit for biological substances must be present for purchase.
  • This sample is not for molecular genetic studies.
CBH170899
1 mL ($43.13)
Will be delivered in 16 to 20 Business Days ($225.00)
  • <
  • 1
  • ...